13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 53 holding rows worth $1,024,667,000.
- Accession
- 0001172661-21-001354
- Filer
- CIK 1792126
- Filed
- 2021-05-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 53 entries on the cover page, a total value of $1,024,667,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,024,667,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 3,156,981 | $232,796,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,743,875 | $124,222,000 | thousands by filing date | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,732,501 | $81,702,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 3,204,392 | $49,764,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 1,846,850 | $46,319,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 1,260,877 | $41,483,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 1,410,000 | $39,508,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,056,812 | $34,346,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 934,602 | $29,122,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 900,000 | $27,621,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 200,000 | $24,046,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 800,000 | $23,896,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 1,010,812 | $18,599,000 | thousands by filing date | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 400,000 | $17,264,000 | thousands by filing date | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 413,458 | $17,229,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 700,000 | $16,282,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 140,000 | $13,243,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,420,500 | $12,472,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 419,853 | $11,861,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 476,547 | $10,837,000 | thousands by filing date | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 260,920 | $10,139,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 480,000 | $9,264,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 250,000 | $9,205,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 550,000 | $9,191,000 | thousands by filing date | |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 2,300,000 | $7,705,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,200,000 | $7,416,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 400,000 | $7,404,000 | thousands by filing date | |
| LANDOS BIOPHARMA INC | 515069102 | CMN | 734,000 | $7,068,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 200,000 | $6,578,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 300,000 | $6,276,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 125,000 | $5,454,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 500,000 | $5,255,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 150,000 | $4,937,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 800,000 | $4,768,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 159,622 | $4,444,000 | thousands by filing date | |
| VIRACTA THERAPEUTICS INC | 92765F108 | COM | 470,000 | $4,348,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 112,928 | $4,177,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 230,000 | $3,360,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 300,000 | $3,357,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 100,000 | $3,304,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 300,000 | $3,075,000 | thousands by filing date | |
| LUCIRA HEALTH INC | 54948U105 | COM | 250,000 | $3,025,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC COM | 30318F100 | Stock | 300,000 | $2,988,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 62,000 | $2,780,000 | thousands by filing date | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 150,000 | $2,775,000 | thousands by filing date | |
| EARGO INC | 270087109 | COM | 50,000 | $2,498,000 | thousands by filing date | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 224,071 | $2,398,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 200,000 | $2,224,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 125,010 | $2,185,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 200,000 | $2,095,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 200,000 | $2,040,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $178,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U102 | *W EXP 06/09/202 | 33,333 | $144,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-21-001354 | this filing | 2021-05-17 | acceptance time not in the bulk data set |